ChemPartner PharmaTech Co Ltd (300149) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.012x

Based on the latest financial reports, ChemPartner PharmaTech Co Ltd (300149) has a cash flow conversion efficiency ratio of 0.012x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.21 Million ≈ $4.13 Million USD) by net assets (CN¥2.37 Billion ≈ $347.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of ChemPartner PharmaTech Co Ltd to measure how many days the company can operate on defensive assets alone.

ChemPartner PharmaTech Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how ChemPartner PharmaTech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ChemPartner PharmaTech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ChemPartner PharmaTech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pasifik Gayrimenkul Yatirim Ortakligi AS IS:PSGYO	-0.147x
REGAL PARTNERS LTD. F:OC7	N/A
STINGRAY GROUP INC. F:317A	N/A
Eson Precision Ind Co Ltd TW:5243	0.063x
Sichuan Discovery Dream Science & Technology Co.Ltd SHE:301213	N/A
LX Semicon Co. Ltd KQ:108320	0.018x
Dat Xanh Real Estate Service Contructions Corp VN:DXG	0.024x
Mühlbauer Holding AG XETRA:MUB	0.114x

Annual Cash Flow Conversion Efficiency for ChemPartner PharmaTech Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of ChemPartner PharmaTech Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see market value of ChemPartner PharmaTech Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.30 Billion ≈ $190.28 Million	CN¥190.50 Million ≈ $27.88 Million	0.146x	+7.83%
2024-12-31	CN¥1.24 Billion ≈ $181.17 Million	CN¥168.21 Million ≈ $24.61 Million	0.136x	+31.45%
2023-12-31	CN¥1.46 Billion ≈ $213.77 Million	CN¥150.99 Million ≈ $22.09 Million	0.103x	-6.04%
2022-12-31	CN¥2.39 Billion ≈ $349.14 Million	CN¥262.46 Million ≈ $38.41 Million	0.110x	-42.15%
2021-12-31	CN¥1.99 Billion ≈ $291.06 Million	CN¥378.22 Million ≈ $55.35 Million	0.190x	+35.89%
2020-12-31	CN¥2.45 Billion ≈ $358.86 Million	CN¥343.16 Million ≈ $50.22 Million	0.140x	+49.86%
2019-12-31	CN¥2.30 Billion ≈ $337.05 Million	CN¥215.07 Million ≈ $31.47 Million	0.093x	-15.36%
2018-12-31	CN¥2.20 Billion ≈ $322.59 Million	CN¥243.19 Million ≈ $35.59 Million	0.110x	+45.29%
2017-12-31	CN¥835.45 Million ≈ $122.25 Million	CN¥63.43 Million ≈ $9.28 Million	0.076x	-17.96%
2016-12-31	CN¥769.93 Million ≈ $112.67 Million	CN¥71.26 Million ≈ $10.43 Million	0.093x	-33.47%
2015-12-31	CN¥723.81 Million ≈ $105.92 Million	CN¥100.69 Million ≈ $14.73 Million	0.139x	+62.47%
2014-12-31	CN¥696.53 Million ≈ $101.92 Million	CN¥59.63 Million ≈ $8.73 Million	0.086x	+23.89%
2013-12-31	CN¥670.29 Million ≈ $98.08 Million	CN¥46.32 Million ≈ $6.78 Million	0.069x	-19.60%
2012-12-31	CN¥640.90 Million ≈ $93.78 Million	CN¥55.09 Million ≈ $8.06 Million	0.086x	+350.62%
2011-12-31	CN¥611.46 Million ≈ $89.48 Million	CN¥11.66 Million ≈ $1.71 Million	0.019x	-47.63%
2010-12-31	CN¥571.30 Million ≈ $83.60 Million	CN¥20.81 Million ≈ $3.05 Million	0.036x	-72.23%
2009-12-31	CN¥101.26 Million ≈ $14.82 Million	CN¥13.28 Million ≈ $1.94 Million	0.131x	-64.72%
2008-12-31	CN¥58.36 Million ≈ $8.54 Million	CN¥21.70 Million ≈ $3.18 Million	0.372x	-59.35%
2007-12-31	CN¥24.25 Million ≈ $3.55 Million	CN¥22.19 Million ≈ $3.25 Million	0.915x	--

About ChemPartner PharmaTech Co Ltd

SHE:300149 China Biotechnology

Market Cap

$562.54 Million

CN¥3.84 Billion CNY

Market Cap Rank

#11826 Global

#3438 in China

Share Price

CN¥7.72

Change (1 day)

-1.15%

52-Week Range

CN¥7.68 - CN¥14.24

All Time High

CN¥24.07